Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
- 1 September 2016
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 15 (10) , 1089-1102
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Fingolimod—A sphingosine‐like molecule inhibits vesicle mobility and secretion in astrocytesGlia, 2012
- Coactivation of NMDA Receptors by Glutamate and d-Serine Induces Dilation of Isolated Middle Cerebral ArteriesJournal of Cerebral Blood Flow & Metabolism, 2011
- Analysis of the mitochondrial proteome in multiple sclerosis cortexBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patientsAnnals of Neurology, 2010
- Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cellsCell Death & Differentiation, 2010
- Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulationTrends in Molecular Medicine, 2010
- Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtinNature Medicine, 2009
- Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptorsAnnals of Neurology, 2009
- Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-d-aspartate (NMDA) receptor activationBiochemical Pharmacology, 2007